Rapt Therapeutics shares owned by Euclidean Capital
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Euclidean Capital
from 13F filings
Historical chart of Euclidean Capital investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by Euclidean Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $16M | 658k | 24.85 |
| 2023-09-30 | $11M | 658k | 16.62 |
| 2023-06-30 | $11M | 571k | 18.70 |
| 2023-03-31 | $7.9M | 433k | 18.35 |
| 2022-12-31 | $8.6M | 433k | 19.80 |
| 2022-09-30 | $10M | 433k | 24.06 |
| 2022-06-30 | $7.9M | 433k | 18.25 |
| 2022-03-31 | $9.5M | 433k | 21.99 |
| 2021-12-31 | $16M | 433k | 36.73 |
| 2021-09-30 | $20M | 635k | 31.05 |
| 2021-06-30 | $23M | 736k | 31.79 |
| 2021-03-31 | $16M | 736k | 22.20 |
| 2020-12-31 | $15M | 736k | 19.75 |